Close Menu

NEW YORK (GenomeWeb) - Biocept today after the close of the market reported a 300 percent increase year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2014, Biocept's total revenues increased to $76,000 from $19,000 in the prior-year fourth quarter, primarily related to higher commercial test volume, the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.